Concepedia

Vincenzo Catalano

VC

Statistics

Publications

80

Citations

6.2K

H-Index

45

Active since

1999

Affiliations

University of Urbino(Current)

Università Campus Bio-Medico

San Salvatore Hospital

Ospedali Riuniti Marche Nord

Azienda Ospedaliera Treviglio

Vincenzo Catalano is an author at University of Urbino specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1999–2023

80

Publications

80

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

Fotios Loupakis, Annamaria Ruzzo, Chiara Cremolini et al. · British Journal of Cancer · 2009 · 557 citations · Full text

Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

Stefano Cascinu, Vincenzo Catalano, L. Cordella et al. · Journal of Clinical Oncology · 2002 · 415 citations

Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.

Giammaria Fiorentini, Camillo Aliberti, Massimo Tilli et al. · PubMed · 2012 · 331 citations

Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

Annamaria Ruzzo, Francesco Graziano, Fotios Loupakis et al. · Journal of Clinical Oncology · 2007 · 264 citations · Full text

Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.

Stefano Cascinu, Maria Pia Staccioli, Giulio Gasparini et al. · PubMed · 2000 · 209 citations

, , +17

1–5 of 80